Berkshire Hathaway Completes $9.7 Billion OxyChem Acquisition
Berkshire Hathaway has finalized its $9.7 billion purchase of OxyChem from Occidental, acquiring the third-largest U.S. producer of PVC, chlor-alkali and chlorinated organic chemicals. The deal integrates OxyChem’s North American facilities under Berkshire’s diverse industrial and manufacturing operations, expanding its critical-chemicals portfolio.
1. Acquisition Details
Berkshire Hathaway closed its acquisition of OxyChem for $9.7 billion, adding a top-three U.S. manufacturer of polyvinyl chloride, chlor-alkali and chlorinated organic chemicals, along with calcium chloride operations. The purchase expands Berkshire’s manufacturing footprint across North America and enhances its exposure to critical-chemicals markets.
2. Strategic Rationale
OxyChem’s products underpin water treatment, pharmaceuticals, healthcare and industrial applications, aligning with Berkshire’s focus on essential, high-barrier businesses. Continued management by OxyChem CEO Wade Alleman aims to ensure operational continuity while integrating the unit into Berkshire’s broader industrial portfolio.